v3.26.1
Earnings (Loss) Per Share
3 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Earnings (Loss) Per Share

10 Earnings (Loss) Per Share

 

Basic earnings (loss) per share are computed by dividing net income (loss) by the weighted-average number of common shares outstanding, excluding shares of unvested restricted common stock. Shares of restricted stock as well as the Series A Warrants are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. The Series A Warrants are included in the calculation of diluted earnings per share to the extent that the warrants are dilutive and vesting conditions have been satisfied. Potential common shares are excluded from the computation when their effect is antidilutive. Basic and diluted net loss per common share is the same for the three months ended March 31, 2026 and 2025 because all stock options, unvested restricted common stock, and warrants are anti-dilutive.

 

EPS Computation  Three months
ended
March 31, 2026
   Three months
ended
March 31, 2025
 
Net loss available to common shareholders  $(1,112,244)  $(522,033)
           
Weighted-average common shares - basic   4,429,508    3,203,331 
           
Effect of dilutive stock option   -    - 
Effect of dilutive unvested restricted stock   -    - 
Weighted-average common shares – diluted   4,429,508    3,203,331 
           
Loss per share, basic  $(0.25)  $(0.16)
Loss per share, diluted  $(0.25)  $(0.16)

 

 

The following are excluded from the calculation of diluted loss per share as their effect is antidilutive:

 

As of March 31, 2026:

 

Convertible preferred stock (as converted to common stock):

 

Series Seed 2 Preferred stock: 115,038 shares

 

Series Seed 1 Preferred stock: 516,298 shares

 

Series A Preferred stock: 611,299 shares

 

Stock options: 711,751 options outstanding

 

Unvested restricted stock awards: 1,485,666 shares

 

Series A Warrants: 893,393 shares, unvested

 

As of March 31, 2025:

 

Convertible preferred stock (as converted to common stock):

 

Series Seed 2 Preferred stock:115,038 shares

 

Series Seed 1 Preferred stock: 516,298 shares

 

Stock options: 153,760 options outstanding

 

Unvested restricted stock awards: 2,054,238 shares

 

All share and per share amounts have been retroactively adjusted to reflect the 2-for-1 forward stock split effected on August 31, 2025, and the 3.57-for-1 forward stock split effected on May 14, 2026 in connection with the Company’s IPO, in accordance with ASC 260.